Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology
Petra Kukanja(Karolinska Institutet), Gonçalo Castelo‐Branco(Karolinska Institutet), Markus M. Hilscher(Stockholm University), Eneritz Agirre(Karolinska Institutet), Tomas Olsson(Karolinska University Hospital), André Ortlieb Guerreiro‐Cacais(Karolinska University Hospital), Chao Zheng(Centre for Addiction and Mental Health), Chika Yokota(Stockholm University), Leslie A. Kirby(Johns Hopkins University), Amitha Raman(Stockholm University), Christoffer Mattsson Langseth(Stockholm University), Mats Nilsson(Stockholm University), Katarína Tiklová(Stockholm University), Christophe Avenel(Science for Life Laboratory)
Cited by 106
Related Papers
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination
|Nature Communications|2019|426
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
|Nature Communications|2017|348
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
|Annals of Neurology|2010|347
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
|Multiple Sclerosis Journal|2012|236